China Medical purchases Molecular Diagnostic's HPV detection system

10/7/2008 | Forbes

China Medical Technologies has gained rights to market a human papillomavirus detection system from Molecular Diagnostic Technologies in a $345 million deal expected to be finalized by early 2009. The agreement involves Molecular Diagnostic's HPV-DNA Biosensor Chip -- which can pinpoint 24 common HPV strains -- and Surface Plasmon Resonance-based Analysis System -- which examines data gathered from the chip.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
Bend, OR
Clinical Appeals RN
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ